There are 2789 resources available
256P - PI3K mutation is associated with reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer
Presenter: Keechilat Pavithran
Session: ePoster Display
257P - Health-related quality of life (HRQoL) in the ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
Presenter: Sibylle Loibl
Session: ePoster Display
349P - The amount of cancer stem cells and the sensitivity to anticancer drugs in glioblastoma primary cell culture
Presenter: Olga Susova
Session: ePoster Display
350P - Molecular profiling of tumor tissue and tumor-derived cell lines in patients with glioblastoma
Presenter: Tatiana Nasedkina
Session: ePoster Display
351P - Impact of time to initiation post-operative adjuvant chemo-radiation in glioblastoma multiform: A systematic review
Presenter: Sudibio Sudibio
Session: ePoster Display
259P - Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
Presenter: Michaela Tsai
Session: ePoster Display
260P - High enrichment of ATRX mutations in lung and liver metastasis of breast cancer
Presenter: Rongrong Chen
Session: ePoster Display
356P - Redo surgery in relapsed glioblastoma multiforme: A comparative cohort analysis of a single institution experience
Presenter: Selvaraj Giridharan
Session: ePoster Display
357P - A phase II study of anlotinib in the treatment of recurrent high-grade glioma
Presenter: Hui Dai
Session: ePoster Display
358P - Anlotinib plus temozolomide for recurrent glioma: A single-center, retrospective study of 30 cases
Presenter: Yuandong Cao
Session: ePoster Display